CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,341 enrolled
Drug / intervention
PCV GSK1024850A +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01311024
NCT01311024N/ACompleted
CompareCT.gov

Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage: a FinIP Effectiveness Trial Satellite Study

Arto Palmu·observational·Posted Mar 9, 2011·Updated Mar 1, 2021

In Brief

An observational study evaluating PCV GSK1024850A and hepatitis B vaccine or hepatitis A vaccine for Pneumococcal Infections. Completed, enrolled 2,341 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the indirect effects of a pneumococcal conjugate vaccine administered to infants on vaccinees' elder non-vaccinated siblings aged 3 to 7 years.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPneumococcal Infections
CountriesFinland
CollaboratorsGlaxoSmithKline

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 9, 2011
Enrollment StartApr 1, 2011
Primary CompletionJun 1, 2013
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 15.3 years ago

Interventions

PCV GSK1024850Abiological

2 to 4 doses administered to the siblings in the cluster-randomized Finnish Invasive pneumococcal Disease Trial (ClinicalTrials.gov Identifier:NCT00861380)

hepatitis B vaccine or hepatitis A vaccinebiological

2 to 4 doses administered to the siblings in the cluster-randomized Finnish Invasive pneumococcal Disease Trial (ClinicalTrials.gov Identifier:NCT00861380)